Skip to main content
. 2026 Jun 7;15(6):581. doi: 10.3390/antibiotics15060581
BFG Bacteroides fragilis group
CDI Clostridioides difficile infections
EMA The European Medicines Agency
FDA The U.S. Food and Drug Administration
MDR Multidrug resistance
MIC Minimal inhibitory concentration
PFOR Pyruvate ferredoxin oxidoreductase
SCR Sustained clinical response